title: Response to 'Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients' by Mariné-Barjoan et al.
authors.forename: Elisiane L
authors.initials: EL
authors.lastname: Paul
authors.forename: Nêmora T
authors.initials: NT
authors.lastname: Barcellos
authors.forename: Ajaccio
authors.initials: A
authors.lastname: Brandão
authors.forename: Regis
authors.initials: R
authors.lastname: Kreitchmann
authors.forename: Sandra C
authors.initials: SC
authors.lastname: Fuchs
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018450:Disease Progression; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000473:pathology*; D012107:Research Design
chemical_list: D019380:Anti-HIV Agents